 |
|
|
| |
Randomized, multicenter, double-blind clinical trial designed to evaluate the safety and convenience of switching from dolutegravir/lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV, good virologic control and neuropsychiatric comorbidities: Week 24 results from the GESIDA 11920 - MIND Study.
|
| |
| |
Corona Mata D, Crussells, MJ, Velasco Arribas M, Mican R, Ryan P, Gallo M, Tiraboschi, J, Cabello Clotet N, Molero M, Artigues Serra F, Mena A, de la Fuente Moral S, Perez J, Diaz Almidon M, Gil P; Perez Valero I.
|
| |
|
|
|
|
|
